Page 3 - Vida Investments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vida investments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vida Investments Today - Breaking & Trending Today

Piper Sandler Increases InspireMD (NYSE:NSPR) Price Target to $4.50

InspireMD (NYSE:NSPR – Get Free Report) had its price target hoisted by research analysts at Piper Sandler from $3.50 to $4.50 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Piper Sandler’s price objective points to a potential upside of 38.46% […] ....

United States , Asia Pacific , Piper Sandler , Nottingham Advisors Inc , Renaissance Technologies , Alliance Global Partners , Pura Vida Investments , Avestar Capital , Inspiremd Company Profile , Inspiremd Inc , Get Free Report , Global Partners , Vida Investments , Velan Capital Investment Management , Latin America , Middle East , Prime Delivery System , Nyse Nspr , Boost Price Target ,

UBS Group Trims Akoya Biosciences (NASDAQ:AKYA) Target Price to $7.00

Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price objective trimmed by UBS Group from $12.00 to $7.00 in a report issued on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. AKYA has been the topic of several other reports. BTIG Research reduced their price objective on Akoya Biosciences […] ....

United States , Akoya Biosciences , Asia Pacific , Pura Vida Investments , Morgan Stanley , Securities Exchange Commission , Akoya Biosciences Inc , Kennedy Capital Management , Polar Capital Holdings Plc , Unisuper Management Pty Ltd , Free Report , Get Free Report , Exchange Commission , Water Life Science Advisors , Vida Investments , Super Management Pty Ltd , Capital Management , Capital Holdings Plc , North America , Middle East , Akoya Biosciences Daily , Nasdaq Akya , Lower Price Target , Ubs Group Ag ,